目的 探讨我区肝囊型包虫病临床路径的实施经验。方法 针对我区包虫病定点医院，将已实施临床路径管理的肝囊型包虫病手术患者60例设为临床路径组，未实施临床路径管理的肝囊型包虫病手术病人60例设为对照组，比较两组住院天数、术前准备天数、术后恢复天数、住院费用、国家包虫病救治项目实际报销费用、国家医保报销费用、零支付人数、患者满意度。结果 与对照组比较，患者平均住院天数缩短，住院费减少，术后恢复较快，国家报销后患者零支付比例提高，患者满意度提高，随访率也相应提高（P<0.05）。结论 我区实施肝囊型包虫病临床路径，可规范肝囊型包虫病诊疗模式，减少术后并发症，缩短住院时间，加快术后恢复，减少住院费用，值得推广。

objective To report our experiences of implementing clinical pathway in hepatic cystic echinococcosis (HCE). Methods In our district echinococcosis fixed-point hospital, 120 operated patients with HCR were divided into a clinical pathway group (n=60) and a control group (n=60, non-implementation of clinical pathway. Days of hospital stay including days of preoperative preparation and postoperative recovery, and hospital costs including nation echinococcosis treatment project (NETP) actual expenses, reimbursement charges, number of zero pay and patients' satisfaction index of each group were followed-up and compared. Conclusion The implementation of HCE clinical pathway in our region can regulate patterns of diagnostic and treatment for HCE, reduce postoperative complications, shorten hospitalization time, reduce hospital cost, so is worthy of promotion.